Catalyst Pharmaceuticals Inc (STU:CN2) Dividend
Catalyst Pharmaceuticals Inc (STU:CN2) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -5.2%. View its historical dividend record below and compare with dividend-paying peers.
Frequently Asked Questions: STU:CN2 Dividend
Does Catalyst Pharmaceuticals Inc (STU:CN2) pay a dividend?
Catalyst Pharmaceuticals Inc (STU:CN2) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.
Why doesn't Catalyst Pharmaceuticals Inc pay a dividend?
Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Catalyst Pharmaceuticals Inc has returned capital to shareholders via buybacks at a rate of -5.2% over the past 3 years.
What are dividend-paying alternatives to Catalyst Pharmaceuticals Inc?
For dividend-paying alternatives in Catalyst Pharmaceuticals Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.